supp.fit

Fucoxanthin

12 benefits mapped to clinical evidence across supplements.

Dose per serving from research

5 study groups in 5 studies say how much Fucoxanthin participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 1 g to 2.5 g, 40% of 5 study groups.

Daily doseStudy groups
5 mg or less
1
5 mg to 10 mg
0
10 mg to 25 mg
1
25 mg to 50 mg
0
50 mg to 100 mg
0
100 mg to 250 mg
0
250 mg to 500 mg
1
500 mg to 1 g
0
1 g to 2.5 g
2

See every study group

Benefit Evidence

Metabolism
Moderate

Liver fat/ALT/HOMA-IR ↓

Weight/TG/insulin ↓

307 people

Weight/liver fat βˆ’5.5kg

Fitness/fat-burn +12.1%

Memory/insulin +8.9%

265 people

Energy use +12%

Fat burn + aerobic fitness

222 people

Fat burn ↑

+12.1% fat oxidation

222 people

Weight βˆ’5.5 kg

Weight βˆ’1.4 kg

No extra loss

222 people

ALT/CAP/HOMA-IR ↓

Liver fat ↓

193 people

↓ HOMA-IR, ALT

↓ HOMA-IR, insulin

85 people

Hormone balance: insulin↓ HOMA-IR↓

Hormone balance: ALT↓ CAP↓

85 people

Aerobic capacity +2.8

Fat burning +12.1%

Bone density +0.020

71 people

Faster reaction, better vigor

Executive function gains

61 people

Memory +8.9%

Attention; insulin ↓4.63

43 people

Inflammation down, IL-6 -2.0

Steatosis/ALT down, HOMA-IR down

42 people

Research sources

Metabolism (4)
  1. Effects of Supplementation with a Microalgae Extract from Phaeodactylum tricornutum Containing Fucoxanthin on Cognition and Markers of Health in Older Individuals with Perceptions of Cognitive Decline

    PubMed ID: 39275314

    Older adults with subjective cognitive decline had improved insulin markers (fasting insulin, HOMA-IR/QUICKI), supporting metabolic benefits.

  2. Effects of Supplementation with Microalgae Extract from Phaeodactylum tricornutum (Mi136) to Support Benefits from a Weight Management Intervention in Overweight Women

    PubMed ID: 38613023

    Phaeodactylum extract improved resting fat oxidation and aerobic capacity in a diet+exercise trial, indicating metabolic shifts favoring fat use.

  3. The effects of Xanthigen in the weight management of obese premenopausal women with non-alcoholic fatty liver disease and normal liver fat

    PubMed ID: 19840063

    Large RCT of a fucoxanthin-containing product produced substantial weight loss and increased resting energy expenditure, strong metabolic signal (product combined with pomegranate oil).

  4. Fucoidan and Fucoxanthin Attenuate Hepatic Steatosis and Inflammation of NAFLD through Modulation of Leptin/Adiponectin Axis

    PubMed ID: 33809062

    6‑month RCT in NAFLD improved HOMA-IR and liver steatosis with combined fucoidan+fucoxanthin β€” metabolic benefits observed though combo product limits attribution.

Healthy aging (3)
  1. Effects of Supplementation with a Microalgae Extract from Phaeodactylum tricornutum Containing Fucoxanthin on Cognition and Markers of Health in Older Individuals with Perceptions of Cognitive Decline

    PubMed ID: 39275314

    Cognitive improvements and improved insulin sensitivity in older adults support aspects of healthy aging.

  2. Effects of Supplementation with Microalgae Extract from Phaeodactylum tricornutum (Mi136) to Support Benefits from a Weight Management Intervention in Overweight Women

    PubMed ID: 38613023

    Trial showed bone preservation, improved aerobic capacity and increased fat oxidation in overweight women β€” outcomes relevant to healthy aging.

  3. The effects of Xanthigen in the weight management of obese premenopausal women with non-alcoholic fatty liver disease and normal liver fat

    PubMed ID: 19840063

    Weight loss and increased REE in obese women may support metabolic health during aging, though product was a combination.

Energy & Fatigue (2)
  1. The effects of Xanthigen in the weight management of obese premenopausal women with non-alcoholic fatty liver disease and normal liver fat

    PubMed ID: 19840063

    Increased resting energy expenditure observed in the Xanthigen trial supports an effect on energy metabolism (though product combined).

  2. Effects of Supplementation with Microalgae Extract from Phaeodactylum tricornutum (Mi136) to Support Benefits from a Weight Management Intervention in Overweight Women

    PubMed ID: 38613023

    Improved VO2peak and fat oxidation suggest improved physiological stamina and ability to sustain exercise.

Fat burn (2)
  1. Effects of Supplementation with Microalgae Extract from Phaeodactylum tricornutum (Mi136) to Support Benefits from a Weight Management Intervention in Overweight Women

    PubMed ID: 38613023

    Increased resting fat oxidation indicates physiological promotion of fat utilization even if total weight loss vs placebo was not greater.

  2. The effects of Xanthigen in the weight management of obese premenopausal women with non-alcoholic fatty liver disease and normal liver fat

    PubMed ID: 19840063

    Xanthigen RCT produced substantial weight loss and reduced liver fat in obese women, consistent with body-fat reduction (combination product).

Weight management (2)
  1. Effects of Supplementation with Microalgae Extract from Phaeodactylum tricornutum (Mi136) to Support Benefits from a Weight Management Intervention in Overweight Women

    PubMed ID: 38613023

    No additional weight loss vs placebo but increased resting fat oxidation β€” mechanistic support for body-composition effects.

  2. The effects of Xanthigen in the weight management of obese premenopausal women with non-alcoholic fatty liver disease and normal liver fat

    PubMed ID: 19840063

    Large RCT with fucoxanthin-containing Xanthigen showed clinically meaningful weight loss and increased REE over 16 weeks (combination product).

Liver support (2)
  1. The effects of Xanthigen in the weight management of obese premenopausal women with non-alcoholic fatty liver disease and normal liver fat

    PubMed ID: 19840063

    Xanthigen (fucoxanthin+pomegranate oil) RCT reported reductions in liver fat in obese women β€” strong liver-fat signal though combination product limits sole attribution.

  2. Fucoidan and Fucoxanthin Attenuate Hepatic Steatosis and Inflammation of NAFLD through Modulation of Leptin/Adiponectin Axis

    PubMed ID: 33809062

    6‑month randomized clinical trial in NAFLD showed reductions in CAP (hepatic steatosis) and ALT vs placebo with the fucoidan+fucoxanthin supplement β€” strongest human liver evidence.

Blood sugar (2)
  1. Fucoidan and Fucoxanthin Attenuate Hepatic Steatosis and Inflammation of NAFLD through Modulation of Leptin/Adiponectin Axis

    PubMed ID: 33809062

    NAFLD 6‑month RCT lowered HOMA-IR significantly versus placebo (combo product) β€” supports improved insulin resistance.

  2. Effects of Supplementation with a Microalgae Extract from Phaeodactylum tricornutum Containing Fucoxanthin on Cognition and Markers of Health in Older Individuals with Perceptions of Cognitive Decline

    PubMed ID: 39275314

    Older adults RCT showed decreased fasting insulin and improved HOMA-IR/QUICKI over 12 weeks β€” clear glucose/insulin benefits.

Hormone balance (2)
  1. Fucoidan and Fucoxanthin Attenuate Hepatic Steatosis and Inflammation of NAFLD through Modulation of Leptin/Adiponectin Axis

    PubMed ID: 33809062

    Improved HOMA-IR in NAFLD trial indicates better insulin-mediated hormonal balance, though product was combined.

  2. Effects of Supplementation with a Microalgae Extract from Phaeodactylum tricornutum Containing Fucoxanthin on Cognition and Markers of Health in Older Individuals with Perceptions of Cognitive Decline

    PubMed ID: 39275314

    Demonstrated decreases in fasting insulin and improved HOMA-IR/QUICKI, indicating meaningful effects on insulin (a key metabolic hormone).

Endurance (1)
  1. Effects of Supplementation with Microalgae Extract from Phaeodactylum tricornutum (Mi136) to Support Benefits from a Weight Management Intervention in Overweight Women

    PubMed ID: 38613023

    Also improved resting fat oxidation (mechanism that can support endurance by sparing glycogen).

Mood balance (1)
  1. Effects of Dietary Supplementation of a Microalgae Extract Containing Fucoxanthin Combined with Guarana on Cognitive Function and Gaming Performance

    PubMed ID: 37111136

    Gamers trial reported some mood/vigor improvements with a microalgae extract containing fucoxanthin and guarana; mood signal present but confounded by caffeine.

Mental clarity (1)
  1. Effects of Supplementation with a Microalgae Extract from Phaeodactylum tricornutum Containing Fucoxanthin on Cognition and Markers of Health in Older Individuals with Perceptions of Cognitive Decline

    PubMed ID: 39275314

    Double-blind RCT in older adults with subjective cognitive decline reported better memory and attention over 12 weeks β€” direct cognitive benefit.

Inflammation (1)
  1. Fucoidan and Fucoxanthin Attenuate Hepatic Steatosis and Inflammation of NAFLD through Modulation of Leptin/Adiponectin Axis

    PubMed ID: 33809062

    NAFLD trial lowered ALT and hepatic steatosis (inflammatory liver markers) and improved HOMA-IR; intervention included fucoidan so attribution to FX alone is uncertain.

Similar by evidence

Supplements the same benefits carry qualifying findings for β€” a fact about the evidence graph, not a recommendation to swap.

Products with Fucoxanthin

Search all

31 products whose verified label declares Fucoxanthin β€” not every bottle that mentions it in a title.